539 related articles for article (PubMed ID: 11833860)
1. A randomized, double blind, placebo-controlled multicenter trial comparing the effects of three doses of orally administered sodium oxybate with placebo for the treatment of narcolepsy.
Sleep; 2002 Feb; 25(1):42-9. PubMed ID: 11833860
[TBL] [Abstract][Full Text] [Related]
2. A double-blind, placebo-controlled study demonstrates sodium oxybate is effective for the treatment of excessive daytime sleepiness in narcolepsy.
Xyrem International Study Group
J Clin Sleep Med; 2005 Oct; 1(4):391-7. PubMed ID: 17564408
[TBL] [Abstract][Full Text] [Related]
3. A 12-month, open-label, multicenter extension trial of orally administered sodium oxybate for the treatment of narcolepsy.
Sleep; 2003 Feb; 26(1):31-5. PubMed ID: 12627729
[TBL] [Abstract][Full Text] [Related]
4. Sodium oxybate: new drug. Fewer attacks of cataplexy in some patients.
Prescrire Int; 2007 Jun; 16(89):98-101. PubMed ID: 17582923
[TBL] [Abstract][Full Text] [Related]
5. Further evidence supporting the use of sodium oxybate for the treatment of cataplexy: a double-blind, placebo-controlled study in 228 patients.
Xyrem International Study Group
Sleep Med; 2005 Sep; 6(5):415-21. PubMed ID: 16099718
[TBL] [Abstract][Full Text] [Related]
6. The nightly administration of sodium oxybate results in significant reduction in the nocturnal sleep disruption of patients with narcolepsy.
Black J; Pardi D; Hornfeldt CS; Inhaber N
Sleep Med; 2009 Sep; 10(8):829-35. PubMed ID: 19616998
[TBL] [Abstract][Full Text] [Related]
7. Sodium oxybate in the treatment of childhood narcolepsy-cataplexy: a retrospective study.
Mansukhani MP; Kotagal S
Sleep Med; 2012 Jun; 13(6):606-10. PubMed ID: 22445591
[TBL] [Abstract][Full Text] [Related]
8. Sodium oxybate demonstrates long-term efficacy for the treatment of cataplexy in patients with narcolepsy.
U.S. Xyrem Multicenter Study Group
Sleep Med; 2004 Mar; 5(2):119-23. PubMed ID: 15033130
[TBL] [Abstract][Full Text] [Related]
9. Sodium oxybate for cataplexy.
Lemon MD; Strain JD; Farver DK
Ann Pharmacother; 2006 Mar; 40(3):433-40; quiz 581-2. PubMed ID: 16507620
[TBL] [Abstract][Full Text] [Related]
10. Sodium oxybate relieves pain and improves function in fibromyalgia syndrome: a randomized, double-blind, placebo-controlled, multicenter clinical trial.
Russell IJ; Perkins AT; Michalek JE;
Arthritis Rheum; 2009 Jan; 60(1):299-309. PubMed ID: 19116896
[TBL] [Abstract][Full Text] [Related]
11. Sodium oxybate for excessive daytime sleepiness in Parkinson disease: an open-label polysomnographic study.
Ondo WG; Perkins T; Swick T; Hull KL; Jimenez JE; Garris TS; Pardi D
Arch Neurol; 2008 Oct; 65(10):1337-40. PubMed ID: 18852348
[TBL] [Abstract][Full Text] [Related]
12. Treatment of paediatric narcolepsy with sodium oxybate: a double-blind, placebo-controlled, randomised-withdrawal multicentre study and open-label investigation.
Plazzi G; Ruoff C; Lecendreux M; Dauvilliers Y; Rosen CL; Black J; Parvataneni R; Guinta D; Wang YG; Mignot E
Lancet Child Adolesc Health; 2018 Jul; 2(7):483-494. PubMed ID: 30169321
[TBL] [Abstract][Full Text] [Related]
13. A randomized trial evaluating the effectiveness of sodium oxybate therapy on quality of life in narcolepsy.
Weaver TE; Cuellar N
Sleep; 2006 Sep; 29(9):1189-94. PubMed ID: 17040006
[TBL] [Abstract][Full Text] [Related]
14. [Integrated treatment of the symptoms of narcolepsy-cataplexy syndrome with sodium oxybate].
Poza-Aldea JJ
Rev Neurol; 2009 Jan 1-15; 48(1):27-31. PubMed ID: 19145563
[TBL] [Abstract][Full Text] [Related]
15. The effects of sodium oxybate on clinical symptoms and sleep patterns in patients with fibromyalgia.
Scharf MB; Baumann M; Berkowitz DV
J Rheumatol; 2003 May; 30(5):1070-4. PubMed ID: 12734908
[TBL] [Abstract][Full Text] [Related]
16. Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adults.
Roth T; White D; Schmidt-Nowara W; Wesnes KA; Niebler G; Arora S; Black J
Clin Ther; 2006 May; 28(5):689-706. PubMed ID: 16861091
[TBL] [Abstract][Full Text] [Related]
17. Narcolepsy: action of two gamma-aminobutyric acid type B agonists, baclofen and sodium oxybate.
Huang YS; Guilleminault C
Pediatr Neurol; 2009 Jul; 41(1):9-16. PubMed ID: 19520267
[TBL] [Abstract][Full Text] [Related]
18. The efficacy and safety of armodafinil as treatment for adults with excessive sleepiness associated with narcolepsy.
Harsh JR; Hayduk R; Rosenberg R; Wesnes KA; Walsh JK; Arora S; Niebler GE; Roth T
Curr Med Res Opin; 2006 Apr; 22(4):761-74. PubMed ID: 16684437
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
[TBL] [Abstract][Full Text] [Related]
20. Sodium oxybate improves excessive daytime sleepiness in narcolepsy.
Black J; Houghton WC
Sleep; 2006 Jul; 29(7):939-46. PubMed ID: 16895262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
